The research sheds new light on how this enzyme influences glucagon secretion in pancreatic alpha (α) cells, a process crucial for maintaining healthy blood sugar levels. The research ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

As a result, semaglutide and its fellow glucagon-like peptide-1 drugs are ... the lungs, the heart, the alpha cells of the pancreas, and in the kidneys, giving them many different functions ...

A doctor has explained how following one particular diet could not only be beneficial for improving health but may also mean no longer needing certain medication. Speaking to Steven Bartlett on his ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

Tabelecleucel (Atara Biotherapeutics) Allogeneic Epstein-Barr virus (EBV) specific T-cell immunotherapy Treatment ... Semaglutide 7.2mg (Novo Nordisk) Glucagon-like peptide-1 receptor agonist ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...